The Board of Directors of the Ri.MED Foundation recently resolved the awarding of the contract for the construction of the Biomedical Research and Biotechnology Center (BRBC) to a temporary association of enterprises that includes Italiana Costruzioni S.p.A. (leading firm), Gemmo S.p.A. (principal), ISA S.p.A. (principal), and T.AM.CO. S.r.l., for a total amount of € 90.5 million.
The above association of enterprises ranked first in the official ranking of the restricted procedure. On June 3, during its last public session the Awarding Committee read the scores assigned to the technical improvements, opened the financial and temporal bids, and assigned the relevant scores. Adding up the three criteria (technical improvements, financial and temporal aspects), the Committee awarded the overall scores and drafted the final ranking, which was then read publicly.
The newly-established temporary association of enterprises, led by Italiana Costruzioni S.p.A., will therefore have the honor and responsibility to realize, within a period of 3 years, a major construction project of utmost importance in the history of Sicily and of the whole Mediterranean region. The 25,000-square-meter center will be built in Carini, Palermo, and will be key to turn Sicily into a translational “hub” for life sciences, guaranteeing the fast transferability of scientific results into clinical practice: a strategic role both from an economic point of view and for public health.
“The upcoming start of construction work of the Biomedical Research and Biotechnology Center (BRBC) of the Ri.MED Foundation is the result of the hard work of Italian and US authorities. The aim is to create a research hub to break new ground and create new health care products, and at the same time to attract and support businesses in this sector,” said Prof. Bruno Gridelli, Ri.MED Vice President and UPMC International Executive Vice President. “The social and economic impact is going to have profound effects both in Sicily and in the rest of Italy. Many Italian scientists will have the opportunity to remain in or return to their country of origin, and work in one of the world’s most advanced research centers.”
The BRBC executive project was designed by an association of companies led by Hellmuth, Obata & Kassabaum Inc., winner of the international design competition, and approved by the Sicilian Regional Commission for Public Works on October 12, 2016.
ANNEX: Key milestones of the tender process:
The full text of the call, the tender specifications, and all the minutes are available on the website www.fondazionerimed.eu under the section “Call for Tenders- Ongoing Procedures”.
Where we are
Find our medical centers in Italy (Sicily, Lazio, Tuscany)
The Italian division of the University of Pittsburgh Medical Center with facilities in Rome (UPMC Hillman Cancer Center at San Pietro FBF, oncology radiotherapy and UPMC Salvator Mundi International Hospital), Palermo (ISMETT IRCCS, organ transplants and highly specialized therapies and Ri.MED Foundation, research), Chianciano Terme (UPMC Institute for Health, preventive medicine and Medical Gym), Mirabella Eclano (UPMC Hillman Cancer Center at Villa Maria, oncology radiotherapy).
UPMC is an integrated global health enterprise headquartered in Pittsburgh, Pennsylvania. With its clinical, training, research, and managerial knowledge and expertise, UPMC is one of the leading health systems in the United States.
UPMC International offers a full range of health care consulting and management services focused on sharing our clinical, technological and managerial knowledge and expertise with partners around the world, customizing solutions so that patients and regions benefit and thrive.